The firm said an in silico-based development solution, SGsilico, simplifies the process of real-time PCR assay development and it is looking to expand its use in molecular diagnostics.
It added the technology can be used in areas such as food safety, animal and plant.
Seegene said it can reduce assay development time from a typical three to 12 months to less than a week and the cost of the development process can be reduced to one tenth of the conventional way.
Once the customer provides detection targets, they will be provided with ready-to-use, fully configured custom assay kit including oligo nucleotides, optimal enzyme and multiplex real-time PCR condition.
Seegene digitalized its real-time PCR technologies, assay with its universal oligo and these were incorporated with in-silico-based development method.
The firm has also developed a universal fluorescent-labeled oligo system, SGoligo, which can be applied to different targets regardless of target types.